home / stock / humaw / humaw news

HUMAW News and Press, Humacyte Inc. Warrant

Stock Information
Company Name: Humacyte Inc. Warrant
Stock Symbol: HUMAW
Market: NASDAQ
Website: humacyte.com
Menu
HUMAW HUMAW Quote HUMAW Short HUMAW News HUMAW Articles HUMAW Message Board
Get HUMAW Alerts

News, Short Squeeze, Breakout and More Instantly...
HUMAW - Humacyte, Inc. (HUMA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

2026-03-10 14:50:17 ET Humacyte, Inc. (HUMA) Barclays 28th Annual Global Healthcare Conference March 10, 2026 1:00 PM EDT... Read the full article on Seeking Alpha For further details see: Humacyte, Inc. (HUMA) Presents at Barclays 28th Annual Global Healthcare Conference Tr...
HUMAW - Humacyte, Inc. (HUMA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

2026-03-06 15:55:59 ET Humacyte, Inc. (HUMA) TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM EST... Read the full article on Seeking Alpha For further details see: Humacyte, Inc. (HUMA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

HUMAW - Humacyte outlines 12-month cash runway and accelerates Symvess adoption following $56.5M capital raise

2025-11-12 12:22:21 ET More on Humacyte Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript Humacyte: Shares Tank On Fundraising News - What You Need To Know Humacyte Q3 2025 Earnings Preview Humacyte shares sink as it announces pricing of $60M direct offe...

HUMAW - Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript

2025-11-12 12:21:36 ET Humacyte, Inc. (HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Company Participants Laura Niklason - Founder, President, CEO & Director Dale Sander - CFO, Chief Corporate Development Officer & Treasurer ... Read the ful...
HUMAW - Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress

2025-08-12 13:20:47 ET Humacyte Overview Humacyte stock ( HUMA ) plummeted 30% following its second-quarter earnings report . My last report on HUMA followed its first-quarter earnings report. SYMVESS, which is marketed for the treatment of extremity vascular trauma,...

HUMAW - Humacyte targets over 200 hospital access points for Symvess as VAC approvals surge and cost cuts extend cash runway

2025-08-11 10:01:36 ET More on Humacyte Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript Humacyte: Revenue Ramp From Symvess Incoming Humacyte Paradoxically Scales Back As Symvess Begins Its Long Journey Humacyte GAAP EPS of -$0.24 misses by $0.08, reve...

HUMAW - Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

2025-08-11 10:00:54 ET Humacyte, Inc. (HUMA) Q2 2025 Earnings Call August 11, 2025 8:00 A.M. ET Company Participants Dale A. Sander - CFO, Chief Corporate Development Officer & Treasurer Laura E. Niklason - Founder, President, CEO & Director William John ...
HUMAW - Humacyte outlines expansion of Symvess to 45 hospitals while targeting BLA submission for ATEV in dialysis by 2026

2025-05-13 14:29:50 ET More on Humacyte, Humacyte, Inc. WT EXP, etc. Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript Humacyte: Doubts Cast Around Efficacy Of Symvess May Be Hard To Dispel ...

HUMAW - Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

2025-05-13 14:29:05 ET Humacyte, Inc. (HUMA) Q1 2025 Earnings Conference Call May 13, 2025 08:30 AM ET Company Participants Thomas Johnson - Director-Corporate Communications, LifeSci Advisors, IR Laura Niklason - Founder, President and Chief Executive Officer Da...

HUMAW - Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

2025-03-28 13:48:49 ET Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call March 27, 2025, 08:30 AM ET Company Participants Thomas Johnson - Director, Corporate Communications, LifeSci Advisors, IR Laura Niklason - President and CEO Dale Sander - CFO and Chief...
Next 10